West Oak Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
100
| – | – | ﹤0.01% | 293 |
|
|
2025
Q1 | $1 | Hold |
100
| – | – | ﹤0.01% | 297 |
|
|
2024
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 295 |
|
|
2024
Q3 | $3 | Hold |
100
| – | – | ﹤0.01% | 298 |
|
|
2024
Q2 | $233 | Hold |
100
| – | – | ﹤0.01% | 314 |
|
|
2024
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 299 |
|
|
2023
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 305 |
|
|
2023
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 303 |
|
|
2023
Q2 | $497 | Hold |
100
| – | – | ﹤0.01% | 306 |
|
|
2023
Q1 | $494 | Hold |
100
| – | – | ﹤0.01% | 306 |
|
|
2022
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 268 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 308 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 306 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 330 |
|
|
2021
Q4 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 332 |
|